Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Head and Neck Cancer

Free Subscription Articles published in Am J Gastroenterol Retrieve available abstracts of 44 articles: HTML format

Single Articles

April 2024
1. KAMBOJ AK, Goyal R, Vantanasiri K, Sachdeva K, et al
   Clinical Outcomes After Endoscopic Management of Low-Risk and High-Risk T1a Esophageal Adenocarcinoma: A Multicenter Study.
   Am J Gastroenterol. 2024;119:662-670.
   PubMed     Abstract available
   
   
   February 2024
2. POKALA SK, Williams JL, Holub JL, Calderwood AH, et al
   Significant Reduction in the Diagnosis of Barrett's Esophagus and Related Dysplasia During the COVID-19 Pandemic.
   Am J Gastroenterol. 2024;119:251-261.
   PubMed     Abstract available
   
   
   December 2023
3. JIANG H, Chen R, Li Y, Hao C, et al
   Performance of prediction models for esophageal squamous cell carcinoma in general population: a systematic review and external validation study.
   Am J Gastroenterol. 2023 Dec 13. doi: 10.14309/ajg.0000000000002629.
   PubMed     Abstract available
   
   
   November 2023
4. LOW EE, Demb J, Shah SC, Liu L, et al
   Risk of Esophageal Cancer in Achalasia: A Matched Cohort Study Utilizing the Nationwide Veterans Affairs Achalasia Cohort (VA-AC).
   Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002591.
   PubMed     Abstract available
   
   
   
5. NOURELDIN M, Rubenstein JH, Urias E, Berinstein JA, et al
   RACIAL DISPARITY IN ESOPHAGEAL SQUAMOUS CELL CARCINOMA TREATMENT AND SURVIVAL IN THE UNITED STATES.
   Am J Gastroenterol. 2023 Nov 17. doi: 10.14309/ajg.0000000000002606.
   PubMed     Abstract available
   
   
   
6. DUITS LC, Khoshiwal AM, Frei NF, Pouw RE, et al
   An Automated Tissue Systems Pathology Test Can Standardize the Management and Improve Health Outcomes for Patients With Barrett's Esophagus.
   Am J Gastroenterol. 2023;118:2025-2032.
   PubMed     Abstract available
   
   
   October 2023
7. JIANG H, Xin L, Wang L
   Management of Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa or Shallow Submucosal Layer After Endoscopic Resection.
   Am J Gastroenterol. 2023;118:1900.
   PubMed    
   
   
   August 2023
8. ZUO J, Wang W, Li H, Chen C, et al
   Endoscopic submucosal dissection for hypervascularized esophageal squamous cell carcinoma in decompensated cirrhosis with esophageal varices and scars.
   Am J Gastroenterol. 2023 Aug 7. doi: 10.14309/ajg.0000000000002459.
   PubMed    
   
   
   
9. SCHMIDT A, Kuellmer A
   Which Patients Should We Select for Adjuvant Treatment After Endoscopic Resection of Squamous Cell Carcinoma?
   Am J Gastroenterol. 2023;118:1332-1333.
   PubMed    
   
   
   
10. YANG X, Zhao L, Shi A, Chen C, et al
    Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection.
    Am J Gastroenterol. 2023;118:1344-1352.
    PubMed     Abstract available
    
    
    July 2023
11. RUBENSTEIN JH, Burns JA, Arasim ME, Firsht EM, et al
    Yield of Repeat Endoscopy for Barrett's Esophagus After Normal Index Endoscopy.
    Am J Gastroenterol. 2023;118:1168-1174.
    PubMed     Abstract available
    
    
    May 2023
12. KOLB JM, Davis C, Williams JL, Holub J, et al
    Wide Variability in Dysplasia Detection Rate and Adherence to Seattle Protocol and Surveillance Recommendations in Barrett's Esophagus: A Population-Based Analysis Using the GIQuIC National Quality Benchmarking Registry.
    Am J Gastroenterol. 2023;118:900-904.
    PubMed     Abstract available
    
    
    April 2023
13. SPECHLER SJ, El-Serag HB
    Why Has Screening and Surveillance for Barrett's Esophagus Fallen Short in Stemming the Rising Incidence of Esophageal Adenocarcinoma?
    Am J Gastroenterol. 2023;118:590-592.
    PubMed    
    
    
    
14. KOLB JM, Chen M, Tavakkoli A, Gallegos J, et al
    Patient Knowledge, Risk Perception, and Barriers to Barrett's Esophagus Screening.
    Am J Gastroenterol. 2023;118:615-626.
    PubMed     Abstract available
    
    
    January 2023
15. KATADA C, Yokoyama T, Hirasawa D, Iizuka T, et al
    Curative Management After Endoscopic Resection for Esophageal Squamous Cell Carcinoma Invading Muscularis Mucosa or Shallow Submucosal Layer-Multicenter Real-World Survey in Japan.
    Am J Gastroenterol. 2023 Jan 5. doi: 10.14309/ajg.0000000000002106.
    PubMed     Abstract available
    
    
    November 2022
16. RUBENSTEIN JH
    Gastroesophageal Reflux Disease Is Not a Great Screening Criterion: Time to Move on to Other Strategies for Controlling the Burden of Esophageal Adenocarcinoma.
    Am J Gastroenterol. 2022;117:1759-1761.
    PubMed     Abstract available
    
    
    
17. RAJENDRA S
    Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.
    Am J Gastroenterol. 2022;117:1880.
    PubMed    
    
    
    
18. ELURI S, Reddy S, Ketchem CC, Tappata M, et al
    Low Prevalence of Endoscopic Screening for Barrett's Esophagus in a Screening-Eligible Primary Care Population.
    Am J Gastroenterol. 2022;117:1764-1771.
    PubMed     Abstract available
    
    
    October 2022
19. KONDA V, Souza RF, Dunbar KB, Mills JC, et al
    An Endoscopic and Histologic Study on Healing of Radiofrequency Ablation Wounds in Patients With Barrett's Esophagus.
    Am J Gastroenterol. 2022;117:1583-1592.
    PubMed     Abstract available
    
    
    August 2022
20. SHAHEEN NJ, Falk GW, Iyer PG, Souza RF, et al
    Guideline to Practice: Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.
    Am J Gastroenterol. 2022;117:1177-1180.
    PubMed    
    
    
    July 2022
21. COTTON CC, Shaheen NJ, Thrift AP
    Surveillance After Treatment of Barrett's Esophagus Benefits Those With High-Grade Dysplasia or Intramucosal Cancer Most.
    Am J Gastroenterol. 2022;117:1056-1062.
    PubMed     Abstract available
    
    
    
22. SMITH JR, Kamihara J, Church AJ, Asch E, et al
    Thyroid Nodules in Children With Familial Adenomatous Polyposis.
    Am J Gastroenterol. 2022;117:1166-1168.
    PubMed     Abstract available
    
    
    June 2022
23. SANTOS-ANTUNES J, Marques M, Macedo G
    Inverted Endoscopic Submucosal Dissection After Submucosal Tunneling for the Resection of Superficial Submucosal Lesions.
    Am J Gastroenterol. 2022;117:841.
    PubMed    
    
    
    April 2022
24. SHAHEEN NJ, Falk GW, Iyer PG, Souza RF, et al
    Diagnosis and Management of Barrett's Esophagus: An Updated ACG Guideline.
    Am J Gastroenterol. 2022;117:559-587.
    PubMed     Abstract available
    
    
    
25. DIAS E, Marques M, Santos-Antunes J, Morais R, et al
    Radiofrequency Ablation for Esophageal Angiectasias and Barrett's Esophagus With Underlying Varices.
    Am J Gastroenterol. 2022;117:535.
    PubMed    
    
    
    February 2022
26. OVERWATER A, Rueb K, Elias SG, de Bree R, et al
    Esophageal second primary tumors in patients with head and neck squamous cell carcinoma: incidence, risk factors and overall survival.
    Am J Gastroenterol. 2022 Feb 25. pii: 00000434-990000000-00271.
    PubMed     Abstract available
    
    
    
27. ZHAO Y, Li X, Yang S, Tao Y, et al
    Small-Diameter Drug-Eluting Beads-Based Transarterial Chemoemboli-zation (DEB-TACE) for Treating Patients With Esophageal Cancer With Acute Bleeding.
    Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00244.
    PubMed    
    
    
    
28. GREENBERG SB, Shaheen NJ
    Endoscopic Surveillance of Barrett's Esophagus: Using Old Principles and New Technology to Improve Care.
    Am J Gastroenterol. 2022;117:201-204.
    PubMed    
    
    
    
29. CHUA WJ, Wan WK, Yew Tan DM
    A Rare Case of Duodenal Papilla Metastasis From the Gastroesophageal Junction.
    Am J Gastroenterol. 2022;117:213.
    PubMed    
    
    
    January 2022
30. KNABE M, Beyna T, Rosch T, Bergman J, et al
    Hybrid APC in Combination With Resection for the Endoscopic Treatment of Neoplastic Barrett's Esophagus: A Prospective, Multicenter Study.
    Am J Gastroenterol. 2022;117:110-119.
    PubMed     Abstract available
    
    
    December 2021
31. BENZ C, Smith J, Mani R, Musunuru T, et al
    Dysphagia Secondary to Intraluminal Choriocarcinoma of the Gastroesophageal Junction.
    Am J Gastroenterol. 2021;116:2326.
    PubMed    
    
    
    September 2021
32. GAO Y, Xin L, Feng YD, Yao B, et al
    Feasibility and Accuracy of Artificial Intelligence-Assisted Sponge Cytology for Community-Based Esophageal Squamous Cell Carcinoma Screening in China.
    Am J Gastroenterol. 2021 Sep 21. pii: 00000434-990000000-00110.
    PubMed     Abstract available
    
    
    August 2021
33. WANG QL, Lagergren J
    Response to Lai.
    Am J Gastroenterol. 2021;116:1758.
    PubMed    
    
    
    
34. INOUE T, Kanesaka T, Yamamoto S, Tani Y, et al
    Anchoring Method to Prevent Migration of a Covered, Self-Expanding, Metal Stent Placed for Esophageal Perforation.
    Am J Gastroenterol. 2021;116:1582.
    PubMed    
    
    
    
35. CARBONI F, Federici O, Zazza S, Corona F, et al
    A Rare Case of Locally Advanced Squamous Cell Carcinoma of the Esophagogastric Junction With Submucosal Progression and Long-Term Survival.
    Am J Gastroenterol. 2021;116:1762.
    PubMed    
    
    
    July 2021
36. WANG SM, Katki HA, Graubard BI, Kahle LL, et al
    Population Attributable Risks of Subtypes of Esophageal and Gastric Cancers in the United States.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00035.
    PubMed     Abstract available
    
    
    
37. KAMBOJ AK, Gibbens YY, Hagen CE, Wang KK, et al
    Esophageal Epidermoid Metaplasia: Clinical Characteristics and Risk of Esophageal Squamous Neoplasia.
    Am J Gastroenterol. 2021;116:1533-1536.
    PubMed     Abstract available
    
    
    June 2021
38. ZHOU J, Li Z, Ji R, Wang P, et al
    Influence of Sedation on the Detection Rate of Early Cancer and Precancerous Lesions During Diagnostic Upper Gastrointestinal Endoscopies: A Multicenter Retrospective Study.
    Am J Gastroenterol. 2021;116:1230-1237.
    PubMed     Abstract available
    
    
    May 2021
39. LAI RP
    Esophageal Squamous Cell Carcinoma: Time to Predict the Risk?
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98794.
    PubMed    
    
    
    
40. RUMGAY H, Arnold M, Laversanne M, Whiteman DC, et al
    International Trends in Esophageal Squamous Cell Carcinoma and Adenocarcinoma Incidence.
    Am J Gastroenterol. 2021;116:1072-1076.
    PubMed     Abstract available
    
    
    
41. RUBENSTEIN JH, Raghunathan T, Doan C, Schneider J, et al
    Validation of Tools for Predicting Incident Adenocarcinoma of the Esophagus or Esophagogastric Junction.
    Am J Gastroenterol. 2021;116:949-957.
    PubMed     Abstract available
    
    
    April 2021
42. WANG QL, Ness-Jensen E, Santoni G, Xie SH, et al
    Development and Validation of a Risk Prediction Model for Esophageal Squamous Cell Carcinoma Using Cohort Studies.
    Am J Gastroenterol. 2021;116:683-691.
    PubMed     Abstract available
    
    
    
43. HAN S, Kolb JM, Hosokawa P, Friedman C, et al
    The Volume-Outcome Effect Calls for Centralization of Care in Esophageal Adenocarcinoma: Results From a Large National Cancer Registry.
    Am J Gastroenterol. 2021;116:811-815.
    PubMed     Abstract available
    
    
    
44. LONG Y, Lv X, Tang L, Yang J, et al
    A Tubulovillous Adenoma With High-Grade Intraepithelial Neoplasia in Upper Barrett's Esophagus.
    Am J Gastroenterol. 2021;116:628.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Head and Neck Cancer is free of charge.